# Semaglutide FAQ: Direct Answers from the Trial Record

> Semaglutide FAQ — direct, cited answers on safety, kidney effects, dosing, side effects, half-life, oral vs injection, and tirzepatide comparisons.

Direct answers grounded in the trials and reviews, with the relevant numbers cited.

## Is semaglutide safe for the kidneys?

The kidney evidence is favorable. In the FLOW trial of 3,533 adults with type 2 diabetes and chronic kidney disease, once-weekly semaglutide 1.0 mg reduced major kidney-disease events — kidney failure, a 50% or greater eGFR decline, or kidney/cardiovascular death — by 24% versus placebo (HR 0.76; 95% CI 0.66-0.88) [6]. This is the basis for its kidney-outcomes use.

## What were the results of the SELECT cardiovascular trial?

SELECT enrolled 17,604 adults with established cardiovascular disease and overweight or obesity but without diabetes. Once-weekly semaglutide 2.4 mg reduced major adverse cardiovascular events — the composite of cardiovascular death, nonfatal heart attack, or nonfatal stroke — by 20% versus placebo (HR 0.80; 95% CI 0.72-0.90; P<0.001) [3]. It extended cardiovascular benefit to people without diabetes.

## What is semaglutide?

Semaglutide is a GLP-1 receptor agonist: a 31-amino-acid peptide that copies the gut hormone GLP-1 to lower appetite and blood sugar. It is FDA-approved for type 2 diabetes, chronic weight management, cardiovascular risk reduction, and MASH, as a once-weekly injection or once-daily tablet. In STEP 1 it produced a mean weight change of -14.9% at 68 weeks [1].

## What is semaglutide used for?

It is used to lower blood sugar in type 2 diabetes, to support long-term weight management, to reduce cardiovascular risk in established disease, and, since 2025, to treat the fatty-liver disease MASH. In its main weight-management trial, once-weekly 2.4 mg produced a mean body-weight change of -14.9% versus -2.4% with placebo over 68 weeks [1].

## How does semaglutide work?

It activates the GLP-1 receptor, copying a gut hormone. That boosts glucose-dependent insulin release, suppresses glucagon, and slows gastric emptying. Its weight effect is central: in rodents it reached brainstem and hypothalamic appetite circuits (area postrema, arcuate nucleus, parabrachial nucleus), reducing food intake without lowering energy expenditure [22].

## How does semaglutide work for weight loss?

The weight effect is driven by the brain. Semaglutide reaches appetite-control centers and activates satiety neurons while quieting hunger neurons, reducing food intake without lowering energy expenditure [22]. The result in trials was substantial: a mean body-weight change of -14.9% over 68 weeks in STEP 1 versus -2.4% with placebo [1].

## What is the semaglutide dosage for weight loss?

In the STEP 1 weight-management trial the maintenance dose was 2.4 mg once weekly, reached by stepping up from 0.25 mg over about 16 weeks; that dose produced a mean body-weight change of -14.9% at 68 weeks versus -2.4% with placebo [1]. This is reported as a trial parameter, not as dosing advice.

## How many mg is 40 units of semaglutide?

This site does not convert "unit" markings on syringes into milligrams, because such conversions depend on the specific product concentration and are exactly the kind of self-dosing math that leads to errors — a concern the FDA flagged with compounded semaglutide [9]. Semaglutide doses in the trials are reported in milligrams (e.g., 1.0 mg, 2.4 mg) [1].

## What is compounded semaglutide?

Compounded semaglutide is a preparation made by a compounding pharmacy rather than the approved manufactured product. It was permitted during a federally declared shortage (roughly 2022 to early 2025) and curtailed once the shortage was declared resolved [9]. The trial evidence summarized here describes the approved product, which is distinct under the law.

## What are the side effects of semaglutide?

The dominant side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation — mostly mild-to-moderate and worst during dose escalation; a safety review reported nausea in about a third of patients [5]. Other documented concerns include a boxed warning for rodent thyroid tumors [16], increased gallbladder disease [5], and weight regain after stopping [13].

## How long does it take for semaglutide to work?

Glucose and appetite effects begin within the first weeks, but weight loss accumulates over months as the dose is escalated. In STEP 1 the mean -14.9% body-weight change was measured at 68 weeks [1]. People often report reduced appetite early, but the full trial-measured effect reflects more than a year of treatment.

## How long does semaglutide stay in your system?

Semaglutide has an elimination half-life of about one week (commonly cited as 165-168 hours), so it is effectively fully cleared roughly five weeks after the last dose. The long half-life comes from tight albumin binding and DPP-4 resistance, and it is why a multi-week washout is advised before a planned pregnancy [9].

## What is the half-life of semaglutide?

The elimination half-life is approximately one week — about 165-168 hours — for both the subcutaneous and oral forms, with effectively complete clearance around five weeks after the final dose [9]. A systematic review confirmed this long half-life as the basis for once-weekly dosing [25]. It results from albumin binding and resistance to the DPP-4 enzyme.

## Is oral semaglutide as effective as the injection?

A meta-analysis of once-daily oral semaglutide reported efficacy in glycemic control and weight, with cardiovascular outcomes consistent with the GLP-1 receptor agonist class in type 2 diabetes [4]. The oral tablet requires strict fasted dosing because its bioavailability is only about 0.4-1% [20]; higher oral doses have been studied to broaden its effect.

## How long does it take for semaglutide to suppress appetite?

Appetite suppression is often noticed within the first weeks, reflecting the drug's central action: it reaches brainstem and hypothalamic appetite circuits to reduce food intake [22]. The effect is reported as anecdotal experience early on; the trial-measured weight outcomes accrue over many months as the dose is escalated [1].

## Why am I not losing weight on semaglutide?

This site cannot give individual guidance. Trial data show the average response builds over months at the maintenance dose, and that response varies between people — STEP 1 reported a mean of -14.9% at 68 weeks, an average around which individuals differ [1]. Weight also regains after stopping, underscoring that the effect is treatment-dependent [13].

## Does semaglutide make you tired?

Fatigue is reported anecdotally, especially in the first days after a dose and during early weeks, and is often linked to eating or drinking too little (see the effects page). It is not among the dominant trial-documented adverse effects, which are gastrointestinal; a safety review centers nausea and other GI events rather than fatigue [5].

## Is semaglutide a GLP-1?

Yes. Semaglutide is a GLP-1 receptor agonist — a long-acting peptide that activates the glucagon-like peptide-1 receptor, copying the body's own GLP-1 hormone. It shares about 94% of its sequence with native GLP-1 but is engineered to resist the DPP-4 enzyme and bind albumin, extending its half-life to roughly a week [25].

## Does semaglutide cause hair loss?

A pharmacovigilance analysis found a reporting signal for alopecia with semaglutide and tirzepatide [18], and a dermatology study linked telogen effluvium — reversible diffuse shedding — to the magnitude and rate of weight loss [19]. The pattern points to rapid weight loss as the cause rather than a direct drug effect, and the shedding is typically temporary.

## How fast does semaglutide work?

Glucose-lowering and appetite effects start within the first weeks, but the headline weight outcome accrues over more than a year as the dose is escalated to maintenance — STEP 1 measured -14.9% at 68 weeks [1]. Because the dose is titrated slowly to limit nausea, the full effect is deliberately gradual rather than fast.

## What is the difference between semaglutide and tirzepatide?

Tirzepatide activates two incretin receptors (GIP and GLP-1); semaglutide activates GLP-1 alone. In the SURMOUNT-5 head-to-head of 751 adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks (-20.2% vs -13.7%; P<0.001) [23]. Semaglutide retains the more mature cardiovascular and kidney outcome record.

## What is the downside of semaglutide?

The main downsides are gastrointestinal side effects (nausea, vomiting, diarrhea, constipation), worst during dose escalation, which are the leading cause of discontinuation [5][7]. Others include weight regain after stopping [13], some loss of lean muscle mass with rapid weight loss [17], and the formulation and contraindication cautions detailed on the effects page.

---

A regulatory reading desk on the semaglutide record — the trials, the labeling, and the kidney-outcomes evidence summarized and cited, with no clinic behind the desk, no legal counsel offered, and nothing here prescribed or sold.